(Q34548850)

3 August 2017

1 reference

title

Intrathecal ziconotide for refractory chronic pain (English)

1 reference

3 August 2017

0 references

Shalini S Lynch

1

1 reference

3 August 2017

Christine M Cheng

series ordinal

2

1 reference

3 August 2017

Jennie L Yee

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

18 July 2006

1 reference

Annals of Pharmacotherapy

3 August 2017

1 reference

3 August 2017

40

1 reference

3 August 2017

7-8

1 reference

3 August 2017

1293-1300

1 reference

The undertreatment of pain in ambulatory AIDS patients

3 August 2017

1 reference

Are nursing home patients with dementia diagnosis at increased risk for inadequate pain treatment?

21 January 2018

1 reference

Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel

21 January 2018

1 reference

Voltage-gated calcium channels as targets for the treatment of chronic pain

21 January 2018

1 reference

Pharmacotherapeutic potential of omega-conotoxin MVIIA (SNX-111), an N-type neuronal calcium channel blocker found in the venom of Conus magus

21 January 2018

1 reference

Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1G584

1 reference

3 August 2017

1 reference